PCN187 BUDGET IMPACT OF SEQUENTIAL TREATMENT WITH AFATINIB FOLLOWED BY OSIMERTINIB VERSUS FIRST-LINE OSIMERTINIB IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH COMMON EGFR MUTATIONS IN THE NETHERLANDS
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2019 |
Reihe/Periodikum: | Value in Health ; volume 22, page S472 ; ISSN 1098-3015 |
Verlag/Hrsg.: |
Elsevier BV
|
Schlagwörter: | Public Health / Environmental and Occupational Health / Health Policy |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27191141 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1016/j.jval.2019.09.383 |